Free CME from PeerView


Emergency Medicine CME

Medical Learning Institute, Inc.
Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
April 15, 2021
Matthew S. Johnson, MD, FSIR / Richard S. Finn, MD
Medical Learning Institute, Inc.
At the Nexus of Locoregional and Systemic Liver Cancer Therapy: A Multidisciplinary Tumor Board on Improving Outcomes in Intermediate to Advanced HCC
April 14, 2021
Dara L. Aisner, MD, PhD / Joshua Bauml, MD
Medical Learning Institute, Inc.
Precision Decisions in Genomic Testing and Targeted Treatment of NSCLC
April 13, 2021
Hossein Borghaei, DO, MS / Sanjay Mukhopadhyay, MD
Medical Learning Institute, Inc.
The Nuances of Immunotherapy Biomarker Testing in Solid Tumors: Unraveling Complexities and Overcoming Challenges to Improve Outcomes
April 05, 2021
Medical Learning Institute, Inc.
Simulation – Partnering With Peers and Patients: Achieving T2DM Treatment Goals With GLP-1 RA Therapy
March 31, 2021
Medical Learning Institute, Inc.
Data-Based Updates: Practical Application of Recent Evidence on Disease-Modifying Therapies for SMA
March 30, 2021
University of Florida College of Medicine / Medical Learning Institute, Inc.
New Insights: How Does Real-World Evidence Influence VTE Management? A Visual Exploration of Real-World Studies of DOACs
March 23, 2021
Medical Learning Institute, Inc.
Expert Perspectives on the Early Diagnosis of Alzheimer’s Disease and the Promise of Novel Therapies on the Horizon
March 22, 2021
Medical Learning Institute, Inc.
Adopting Telemedicine and Digital Tools for Nonvalvular Atrial Fibrillation Management and Stroke Prevention
March 12, 2021
Credits: 0.50 CME / MOC / CC - ABOHNS
Medical Learning Institute, Inc.
Improving the Management of Chronic Rhinosinusitis With Nasal Polyps: Practical Strategies for Selecting the Right Patients for Targeted Treatment
February 26, 2021
Corey Cutler, MD, MPH, FRCP(C) / Miguel-Angel Perales, MD
The Medical College of Wisconsin
New Perspectives in Acute and Chronic GVHD: Challenges and Opportunities for Improving Prophylaxis and Treatment With Novel Therapeutics
February 23, 2021

Pages